Carcinoembryonic Antigen (CEA) is a glycoprotein tumor marker used for the detection, prognosis, and monitoring of various cancers, particularly colorectal cancer and lung cancer; it serves as an antigen capable of eliciting immune responses in patients; its specialized sialofucosylated glycoforms function as L-selectin and E-selectin ligands, playing a potential role in the metastatic dissemination of colon carcinoma cells; CEA peptide is utilized in immunological and oncological research as a tool for studying tumor biology and immune recognition.